Therefore, we performed IHC analysis of tumor tissues in each group with CD11b, the results showed that CD11b+ cells were significantly increased after VPA/HPTA treatment (1.76 ± 0.24/2.11 ± 0.31) (P <0.01, Figure 3A), there was a small increase after RT-alone (0.95 ± 0.15, P <0.05). The gene discussed is ITGAM; the disease is neoplasm.